
16/05/2025
NAFDAC Director-General, Professor Mojisola Adeyeye, is championing a renewed push for stronger collaboration between Nigeria’s pharmaceutical manufacturers and academic institutions. Her call highlights the urgent need to align university-led research with the pharmaceutical industry to boost local drug and vaccine production.
With over 70% of Nigeria’s medicines currently imported, this shift is critical. The goal? Achieve 70% local production by 2030 through innovation, R&D, and strategic partnerships.
At Pharma West Africa, we stand firmly behind this vision creating a platform where academia, industry leaders, and policymakers come together to drive sustainable growth across Nigeria and the wider West African region.
Via